EUVIMEDEUVIMED entdecken
Crossref

ACSS2 Inhibition Alleviates Cisplatin-Induced Acute Kidney Injury: Insights from Targeted Metabolomics

Wanting Chen, Xian Zhao, Jiaxin Zheng, Zhiru Zheng, Fengxia Qin, Zunjian Zhang, Fengguo Xu iD, Pei Zhang iD

Chemical Research in Toxicology · 20.07.2026 · 39 (7) · 1377-1388

DOI: 10.1021/acs.chemrestox.6c00148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Research in Toxicology, online erschienen am 04.07.2026. Verfasst von Wanting Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Jiangning Chinese Medicine Hospital, China Pharmaceutical University, Nanjing 211100, P. R. China. Hauptthemen laut MEDLINE: Cisplatin, Acute Kidney Injury, Metabolomics, Coenzyme A Ligases. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, State Key Laboratory of Natural Medicines, China Pharmaceutical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinAcute Kidney InjuryMetabolomicsCoenzyme A LigasesAntineoplastic AgentsEnzyme InhibitorsAnimalsHumansMaleMiceOxidative StressCell LineMice, Inbred C57BLAcetate-CoA Ligase

Substanzen

CisplatinCoenzyme A LigasesAntineoplastic AgentsEnzyme InhibitorsACSS2 protein, humanAcetate-CoA Ligase

Autor:innen und Institutionen

  • Affiliated Jiangning Chinese Medicine Hospital, China Pharmaceutical University, Nanjing 211100, P. R. China.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, P. R. China.
  • Department of Pharmacy, Nanjing Drum Tower Hospital, China Pharmaceutical University, Nanjing 210008, P. R. China.
  • School of Pharmacy, China Pharmaceutical University, Nanjing 210009, P. R. China.

ORCID-Profile: Fengguo Xu, Pei Zhang

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University
  • Yunnan Characteristic Plant Extraction Laboratory Co., Ltd.

Zitieren

APA

Chen, W., Zhao, X., Zheng, J., Zheng, Z., Qin, F., Zhang, Z., Xu, F., & Zhang, P. (2026). ACSS2 Inhibition Alleviates Cisplatin-Induced Acute Kidney Injury: Insights from Targeted Metabolomics. Chemical Research in Toxicology, 39(7), 1377-1388. https://doi.org/10.1021/acs.chemrestox.6c00148

Vancouver

Chen W, Zhao X, Zheng J, Zheng Z, Qin F, Zhang Z, et al. ACSS2 Inhibition Alleviates Cisplatin-Induced Acute Kidney Injury: Insights from Targeted Metabolomics. Chemical Research in Toxicology. 2026;39(7):1377-1388. doi:10.1021/acs.chemrestox.6c00148

BibTeX
@article{Chen2026,
  author = {Chen, Wanting and Zhao, Xian and Zheng, Jiaxin and Zheng, Zhiru and Qin, Fengxia and Zhang, Zunjian and Xu, Fengguo and Zhang, Pei},
  title = {ACSS2 Inhibition Alleviates Cisplatin-Induced Acute Kidney Injury: Insights from Targeted Metabolomics},
  journal = {Chemical Research in Toxicology},
  year = {2026},
  volume = {39},
  number = {7},
  pages = {1377--1388},
  doi = {10.1021/acs.chemrestox.6c00148}
}
Kostenlos starten →